Category Specific RSS

cancer

Genetic Technologies partners with CancerIQ to enhance cancer prevention but capital raise struggles

Driving their expertise in genomics-based health and disease testing, Genetic Technologies (ASX: GTG) has partnered CancerIQ, a widely used platform…

1 year ago

Cleo’s ovarian cancer blood test proves more effective than CA125 clinical benchmark and ultrasound

A benchmarking study comparing ovarian cancer diagnostics company Cleo Diagnostics (ASX: COV)’s blood test against ultrasound has been published in…

1 year ago

Noxopharm’s pancreatic cancer treatment drug slows tumour growth in mice, study shows

In 2023, pancreatic cancer transitioned from being a rare form to a common cancer in Australia—a troublesome statistic, seeing as…

2 years ago

Chimeric’s cell therapy drug moves on to Phase 1B trial to treat malignant brain cancer

In 2020, the Department of Health and Aged Care revealed that approximately 2,000 Australians were diagnosed with brain cancer. New…

2 years ago

Starpharma’s DEP shows promising results on prostate cancer patients

Offering some relief for people suffering from prostate cancer, Starpharma (ASX: SPL) might be on the verge of a breakthrough…

3 years ago

This article is like The Magic School Bus

CF33-hNIS-antiPDL1. *moves mouse to x button to close tab* “But wait!” your writer screams from the page, “I promise it's…

3 years ago